Madison Small Cap Fund Boosts Medpace Stake Amid AI Disruption Concerns
Fund dismisses fears of AI reducing drug development spending, citing Medpace's $13.57 billion market cap and 59% annual gain. Madison Small Cap Fund increased its position in Medpace Holdings (MEDP) during Q1 2026, countering concerns over AI disruption in drug developmen